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 ABSTRACT 
 Most cows encounter a state of negative energy bal-
ance during the periparturient period, which may lead 
to metabolic disorders and impaired fertility. The aim 
of this study was to assess the potential of milk fatty 
acids as diagnostic tools of detrimental levels of blood 
plasma nonesterified fatty acids (NEFA), defined as 
NEFA concentrations beyond 0.6 mmol/L, in a data set 
of 92 early lactating cows fed a glucogenic or lipogenic 
diet and subjected to 0-, 30-, or 60-d dry period before 
parturition. Milk was collected in wk 2, 3, 4, and 8 (n 
= 368) and blood was sampled weekly from wk 2 to 8 
after parturition. Milk was analyzed for milk fatty acids 
and blood plasma for NEFA. Data were classified as “at 
risk of detrimental blood plasma NEFA” (NEFA ≥0.6 
mmol/L) and “not at risk of detrimental blood plasma 
NEFA” (NEFA <0.6 mmol/L). Concentrations of 45 
milk fatty acids and milk fat C18:1 cis-9-to-C15:0 ra-
tio were subjected to a discriminant analysis. Milk fat 
C18:1 cis-9 revealed the most discriminating variable 
to identify detrimental blood plasma NEFA. A false 
positive rate of 10% allowed us to diagnose 46% of the 
detrimental blood plasma NEFA cases based on a milk 
fat C18:1 cis-9 concentration of at least 230 g/kg of 
milk fatty acids. Additionally, it was assessed whether 
the milk fat C18:1 cis-9 concentrations of wk 2 could be 
used as an early warning for detrimental blood plasma 
NEFA risk during the first 8 wk in lactation. Cows 
with at least 240 g/kg of C18:1 cis-9 in milk fat had 
about 50% chance to encounter blood plasma NEFA 
values of 0.6 mmol/L or more during the first 8 wk 
of lactation, with a false positive rate of 11.4%. Profit 
simulations were based on costs for cows suffering from 
detrimental blood plasma NEFA, and costs for preven-
tive treatment based on daily dosing of propylene glycol 
for 3 wk. Given the relatively low incidence rate (8% of 
all observations), continuous monitoring of milk fatty 
acids during the first 8 wk of lactation to diagnose det-
rimental blood plasma NEFA does not seem cost effec-
tive. On the contrary, milk fat C18:1 cis-9 of the second 
lactation week could be an early warning of cows at 
risk of detrimental blood NEFA. In this case, selective 
treatment may be cost effective. 
 Key words:   milk fatty acid ,  nonesterified fatty acid , 
 biomarker 
 INTRODUCTION 
 Most transition dairy cows are confronted with 
a negative energy balance (NEB) in early lactation 
caused by 3 primary reasons: increased energy de-
mands at calving, decreased DMI shortly before and 
after calving, and lagging DMI compared with energy 
demand for milk production (Ospina et al., 2010a). Ad-
ditionally, the supply of glucogenic precursors, in par-
ticular ruminal propionate which is largely converted 
into glucose in the liver, is often insufficient (Heuer et 
al., 2000). Accordingly, milk linear odd-chain FA (i.e., 
C15:0 and C17:0) might provide information on the 
cow’s glucose status as they are de novo synthesized 
from propionyl-CoA by rumen bacteria or in the mam-
mary gland (Vlaeminck et al., 2006). 
 Glucose insufficiency in the transition period further 
results in low blood glucose and insulin concentrations, 
inducing body fat mobilization and transportation of 
NEFA to several organs, among them reproductive 
tissues and the liver. In the liver, excessive supply of 
NEFA might result in metabolic disorders such as fatty 
liver and ketosis (Grummer, 1993), which particularly 
take place 2 to 7 wk after parturition. Additionally, 
elevated plasma NEFA concentrations increase the risk 
for displaced abomasum, clinical ketosis, metritis, and 
retained placenta (Ospina et al., 2010a). The critical 
NEFA concentration is about 0.3 mmol/L prepartum 
and 0.57 mmol/L postpartum (Ospina et al., 2010b), 
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whereas a concentration of 1.0 mmol/L or more post-
calving has been associated with increased culling rates 
in the first 2 mo of lactation (LeBlanc et al., 2005; 
Chapinal et al., 2011; Seifi et al., 2011). Furthermore, 
a high blood plasma NEFA concentration seems detri-
mental for dairy cow fertility (Garverick et al., 2013). 
This has been suggested to originate from deteriorated 
oocyte quality (Leroy et al., 2005).
Excessive amounts of NEFA, released during body 
fat mobilization, are also transferred to the milk. As 
these NEFA are particularly rich in long-chain FA, such 
as C18:1 cis-9 and C18:0 (Hostens et al., 2012), con-
centrations in milk fat of those FA might be linked to 
severity of NEB. Therefore, the objective of the current 
study was to assess whether milk FA are potential bio-
markers for detrimental levels of blood plasma NEFA. 
For this objective, milk and blood plasma sampled dur-
ing the first 8 wk after parturition were used. Samples 
were obtained from a large-scale experiment with 92 
early lactating cows receiving either a glucogenic or a 
lipogenic diet in early lactation after a normal (60 d) 
or shortened (30 d) dry period or without dry period. 
The objective was approached in 4 steps: (1) measure-
ment of FA in milk and NEFA in blood plasma; (2) 
discriminant analysis to determine the milk FA with 
the greatest biomarker potential; (3) assessment of the 
potential value of these milk FA as diagnostic and early 
warning biomarkers; and (4) economic validation.
MATERIALS AND METHODS
Experimental Setup, Animals, and Housing
The Institutional Animal Care and Use Committee of 
Wageningen University and Research Center approved 
the experimental protocol. Details about the experi-
mental design have been reported earlier (van Knegsel 
et al., 2014). In short, Holstein-Friesian dairy cows (n 
= 108) were selected from the Dairy Campus Research 
dairy herd (Wageningen University and Research Cen-
ter Livestock Research, Lelystad, the Netherlands) for 
an experiment on the effect of dry period length (0, 
30, and 60 d) and early lactation diet (glucogenic or 
lipogenic) on metabolic health (assessed through blood 
plasma BHBA, NEFA, glucose, IGF-1, and insulin). 
Cows were blocked for parity (primiparous or multipa-
rous), expected calving date, milk production in the 
previous lactation, and BCS and randomly assigned to 
treatments (0, 30, or 60 d) and early lactation ration 
(glucogenic or lipogenic), resulting in a 3 × 2 experi-
mental design. Cows were housed in a freestall with a 
slatted floor and cubicles. During lactation, cows were 
milked twice daily (0500 and 1630 h). The drying-off 
protocol for cows with the 30- and 60-d dry period 
consisted of a transition to the far-off ration at d 7 
before drying off, and milking once daily at d 4 before 
drying off cows. At drying off, cows were treated with 
an intramammary antibiotic (Supermastidol, Virbac 
Animal Health, Barneveld, the Netherlands). Milk 
yield was recorded daily. From the original 108 cows in 
the experiment, 3 cows showed health problems post-
calving and were not considered further. The health 
status of the cows was checked regularly by the animal 
care workers, but no further signs of health problems 
were observed in the 105 cows. Hence, from 105 cows 
of the experiment (17 or 18 in each of the 6 treatment 
groups), milk and blood samples were obtained. Blood 
samples were taken weekly from wk 3 precalving till wk 
8 postcalving. Blood was sampled from the coccygeal 
vein into heparinized tubes. Blood plasma was obtained 
by centrifugation for 15 min at 3,000 × g at 4°C. Blood 
plasma samples were kept at −20°C until analysis for 
plasma metabolites. Milk sampling for FA analysis took 
place every Friday morning in wk 2, 3, 4, and 8 post-
calving. Milk samples were collected in 10-mL tubes 
and were stored at −20°C. Frozen milk samples were 
sent to the Laboratory for Animal Nutrition and Ani-
mal Product Quality (Faculty of Bioscience Engineer-
ing, Ghent University, Belgium). From the 105 cows, 13 
cows were excluded because the data were incomplete 
(missing milk FA of wk 2, 3, 4, and 8 or blood NEFA 
from wk 2 to 8 of lactation). Hence, only 92 of the 105 
cows were used in data analysis.
Prepartum, dry cows received a dry cow ration, lac-
tating cows received a lactating cow ration supporting 
25 kg of milk. From 3 wk prepartum until 100 DIM, all 
cows were fed 1 of the experimental concentrates (lipo-
genic or glucogenic); lactating cows received 1 kg/d of 
standard lactation concentrate in the milking parlor. 
Forage composition consisted prepartum of grass silage, 
corn silage, wheat straw, and a protein source (rapeseed 
meal or soybean meal) in a ratio of 39:25:25:11 (DM 
basis). Postpartum to 100 DIM, forage consisted of 
grass silage, corn silage, straw, and a protein source 
(rapeseed meal or soybean meal) in a ratio 51:34:2:13 
(DM basis; Tables 1 and 2).
Milk Analysis
The FA profile was obtained after milk fat extrac-
tion (mini Röse-Gottlieb method, adapted from Choui-
nard et al., 1997), methylation (Stefanov et al., 2010), 
and gas chromatographic analysis of FAME (Agilent 
Technologies 7890A GC System equipped with a flame 
ionization detector, Agilent Technologies, Santa Clara, 
CA). Samples were injected by split injection (split ra-
tio 1:50). The carrier gas was hydrogen, inlet pressure 
246.38 kPa. Fatty acid peaks were identified based on 
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their retention times. Separation of FAME was realized 
with a Supelco column (SP-2560, Sigma-Aldrich, Belle-
fonte, PA; 75 m × 180 μm × 0.14 μm). The temperature 
program ran from a starting temperature of 70°C for 2 
min, increasing 15°C/min to 150°C; from 150 to 165°C 
by an increase of 1°C/min, then 165°C was held for 12 
min; from 165 to 170°C the temperature increased at 
2°C/min, with 170°C held for 5 min and from 170 to 
215°C, an increase of 5°C/min was applied, with the 
final temperature kept for 10 min. Fatty acid methyl 
esters were determined with Agilent ChemStation 
software (B.04.03; Agilent Technologies) and trideca-
noic acid (C13:0; as triacylglyceride; Sigma, Bornem, 
Belgium) was used as internal standard. Fatty acids 
were expressed as grams per 100 g of FAME. Fatty acid 
peaks were identified through mixtures of methyl ester 
standards (BR2 and BR3, Larodan Fine Chemicals 
AB, Malmö, Sweden; Supelco 37, Supelco Analytical, 
Bellefonte, PA; PUFA-3, Matreya LLC, Pleasant Gap, 
PA) based on retention times. Short-chain FA were cor-
rected for their respective theoretical relative response 
factors (Ackman and Sipos, 1964; Wolff et al., 1995).
Blood Plasma Metabolites
Plasma metabolites were measured enzymatically 
with a selective analyzer (Cobas Mira 2, Hoffmann-La 
Roche, Basel, Switzerland) and by the use of commercial 
kits as described by van Dorland et al. (2009); NEFA 
was measured using commercial kit no. FA115 (Randox 
Laboratories Ltd., Ibach, Switzerland). The principle of 
the assay is as follows: NEFA, in the presence of ATP, 
CoA, and acetyl-CoA synthetase, forms acyl-CoA and 
the by-products AMP and pyrophosphate. Then, the 
product acyl-CoA is oxidized by acetyl-CoA oxidase, 
which produces hydrogen peroxide. Peroxidase acts on 
Table 1. Ingredient and calculated1 chemical composition (g/kg of DM, unless otherwise noted) of glucogenic 
and lipogenic concentrate 
Item Glucogenic Lipogenic
Ingredient (g/kg)   
 Rapeseed meal 112.9 170.4
 Corn 530.8  
 Palm kernel, expeller  212.6
 Sugar beet pulp 72.3 321.0
 Wheat 39.0 61.2
 Soybean hulls 4.9  
 Soybean meal 86.6 16.9
 Soybean meal, formaldehyde treated 22.4 18.4
 Rapeseed meal, formaldehyde treated 34.6 59.4
 Energizer RP102  20.1
 Molasses 57.0 47.0
 Vinasses  39.2
 Palm oil 1.0 11.9
 Calcium carbonate 19.3 10.9
 Magnesium oxide 7.1 4.5
 Sodium chloride 7.5 5.1
 Mineral-vitamin mixture3 2.3 2.4
Calculated chemical composition   
 DM (g/kg of product) 873 879
 CP 181 194
 Crude fat 33 71
 NDF 178 379
 ADF 79 222
 ADL 18 50
 Starch 417 28
 Sugars4 77 103
 Ash 79 90
 DVE5 120 120
 OEB6 12 12
 NEL
7 (MJ/kg of DM) 7.7 7.7
1Based on Centraal Veevoederbureau (CVB) table (CVB, 2005).
2Rumen-protected fat from palm oil (IFFCO International, Por Klang, Malaysia).
3Premix 2016 (Pre-Mervo UA Cooperation, Utrecht, the Netherlands).
4van Vuuren et al. (1993).
5DVE = intestinal digestible protein (Tamminga et al., 1994).
6OEB = degraded protein balance (Tamminga et al., 1994).
7Calculated with the Dutch net energy evaluation (VEM) system (Van Es, 1975).
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the hydrogen peroxide in the presence of 3-methyl-N-
ethyl-N-(β-hydroxyethyl)-aniline and 4-aminoantipy-
rine to form the final reaction product that is a purple 
quinone.
Statistical Analysis, Calculations,  
and Generation of Functions
Descriptive Statistics. Milk fat C18:1 cis-9 con-
centration and blood plasma NEFA were subjected to 
repeated measures ANOVA (ANOVA mixed model of 
SAS; SAS Institute Inc., Cary, NC). Lactation week 
was considered as the repeated effect (wk 2 to 8 for 
blood plasma NEFA and wk 2, 3, 4, and 8 for milk fat 
C18:1 cis-9 concentration). Cow was defined as random 
effect. Dry period length (0, 30, or 60 d), diet (glu-
cogenic or lipogenic), week (2 to 8), and the relevant 
interaction terms were included in the model as fixed 
effects. A first-order autoregressive structure [AR(1)] 
was the best fit and was used to account for within-dry 
period by diet variation of NEFA, whereas a first-order 
heterogeneous structure was used to account for within-
dry period by diet variation of milk fat C18:1 cis-9 
concentration.
NEFA Threshold Definition. The NEFA thresh-
old in postpartum blood plasma samples was set at 0.6 
mmol/L (Ospina et al., 2010a), where NEFA values 
greater than or equal to 0.6 mmol/L were classified as 
1, which stands for “at risk of detrimental blood plasma 
NEFA”; NEFA values lower than 0.6 mmol/L were clas-
sified as 0, which stands for “not at risk of detrimental 
blood plasma NEFA.”
Discriminant Function. The aim of this function 
is to maximize the distance between the categories (i.e., 
to come up with an equation that has a strong discrimi-
natory power between groups). The 45 milk FA, as well 
as the milk fat C18:1 cis-9-to-C15:0 ratio, were sub-
jected to a discriminant analysis performed by SPSS 
Table 2. Ingredient and calculated chemical composition (g/kg of DM, unless otherwise stated) of prepartum 
and postpartum rations1 
Diet
Prepartum ration Postpartum ration
Dry Lactating Glucogenic Lipogenic
Ingredient     
 Grass silage 391 484 338 338
 Corn silage 245 321 227 227
 Soybean meal 38 68 46 46
 Rapeseed meal 79 52 36 36
 Rapeseed straw 2 1 10 10
 Wheat straw 245 13 5 5
 Concentrate 0 56 338 338
Chemical composition     
 DM (g/kg of product) 532 453 561 566
 CP (g/kg of DM) 116 159 167 169
 Crude fat 26 31 31 37
 NDF 527 384 318 389
 ADF 326 229 182 224
 Starch 65 117 215 106
 Sugars2 67 80 82 85
 Ash 74 76 76 80
 DVE3 47 80 87 84
 OEB4 10 21 17 17
 NEL
5 (MJ/kg of DM) 5.26 6.48 6.55 6.52
FA composition6 (g/kg of FAME)
 C12:0 0.83 5.26 0.53 40.0
 C14:0 1.55 3.15 1.13 15.6
 C16:0 136 164 133 370
 C18:0 160 155 139 85.6
 C18:1 cis-9 124 127 215 149
 C18:2 cis-9,cis-12 146 155 261 93.8
 C18:3 cis-9,cis-12,cis-15 397 354 248 169
1Based on realized feed intake.
2van Vuuren et al. (1993).
3DVE = intestinal digestible protein (Tamminga et al., 1994).
4OEB = degraded protein balance (Tamminga et al., 1994).
5Calculated with the Dutch net energy evaluation (VEM) system (Van Es, 1975).
6Analysis of FA composition according to F. Gadeyne, G. V. Ranst, B. Vlaeminck, E. Vossen, P. Van der 
Meeren, and V. Fievez (all from Ghent University, Belgium, unpublished data).
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21.0 (SPSS Inc., Chicago, IL). Discriminant analysis 
was used to identify the most discriminating milk FA 
for classification based on blood plasma NEFA concen-
tration. Given the large variation in range of milk FA, 
standardized canonical discriminant coefficients were 
used to compare variables. Greater absolute values of 
these coefficients correspond to variables with greater 
discriminating ability. After this first exploratory linear 
discriminant analysis, which aimed to identify the most 
discriminating milk FA, a second linear discriminant 
analysis was run in which classification was based on 
the most discriminating milk FA. The performance of 
both classification models (either based on all milk FA 
or on a single milk FA) were assessed through cross-
validated discriminant analysis (default leave-one-out 
procedure in SPSS 21.0).
Empirical Cumulative Probability Distribu-
tions for Diagnosis of Detrimental Blood NEFA. 
Empirical cumulative probability distributions were 
generated expressing the cumulative probability of 
milk fat C18:1 cis-9 concentration. In particular, the 
cumulative probability distribution of milk fat C18:1 
cis-9 concentration in case of elevated and low blood 
plasma NEFA (detrimental blood plasma NEFA cows) 
were considered and denoted g1 and g2, respectively. 
Denoting the milk fat oleic acid (C18:1 cis-9) concen-
tration as O (the random variable under study), the 
corresponding curves were constructed through a step-
wise increase of the milk fat C18:1 cis-9 concentration 
o from the minimum to the maximum value observed 
in the study:
g1(o) = (Number of cases with elevated blood plasma 
NEFA for which O ≤ o)/(Total number of cases  
with elevated blood plasma NEFA in the study), and
g2(o) = (Number of cases with low blood plasma 
NEFA for which O ≤ o)/(Total number of cases  
with low blood plasma NEFA in the study).
Empirical Cumulative Probability Distribu-
tions for Early Warning of Detrimental Blood 
Plasma NEFA. In our study, early warning potential 
for detrimental blood plasma NEFA was assessed. For 
this purpose, milk fat C18:1 cis-9 was determined in wk 
2 after parturition, whereas cows were classified based 
on detrimental blood plasma NEFA from wk 2 to 8. For 
this classification, cows were considered at risk of detri-
mental blood plasma NEFA in early lactation when the 
maximum blood plasma NEFA concentration at any 
time in this 7-wk period was greater than 0.6 mmol/L. 
Empirical probability distributions were generated as 
described previously (diagnosis), but now including 
milk FA data of wk 2 only and the 0 or 1 classification 
based on the maximum blood plasma NEFA concentra-
tion observed in wk 2 till 8 of lactation. The following 
cumulative probability distributions for use in early 
warning were considered: the cumulative probability 
distribution of the milk fat C18:1 cis-9 concentration 
in wk 2 of lactation in cases of elevated and low blood 
plasma NEFA in the first 8 wk in lactation, denoted e1 
and e2, respectively. Denoting the milk fat oleic acid 
(C18:1 cis-9) concentration in wk 2 as O2 (the random 
variable under study), the corresponding curves were 
constructed through a stepwise increase of the milk fat 
C18:1 cis-9 concentration o from the minimum to the 
maximum value observed in the study:
e1(o) = (Number of elevated-blood plasma NEFA 
cows in the first 8 wk in lactation for which O2 ≤ o)/
(Total number of cows with elevated blood plasma 
NEFA in first 8 wk in lactation), and
e2(o) = (Number of low-blood plasma NEFA cows  
in the first 8 wk in lactation for which O2 ≤ o)/ 
(Total number of cows with low blood plasma  
NEFA in first 8 wk in lactation).
Logistic Curve Fitting. Further, a logistic curve 
was fitted to the empirical cumulative probability dis-
tributions. This curve is described based on the slope 
(β0), the inflection point of the curve (β1), and the up-
per limit (β2), which here equals 1:
 y
x
=
+ − × −( )⎡⎣⎢ ⎤⎦⎥
β
β β
2
0 11 exp
. 
Economic Cost Function for Prevention of 
Detrimental Blood Plasma NEFA. The expected 
economic cost of detrimental blood plasma NEFA was 
calculated based on following cost parameters and 
probabilities:
 a  = Financial loss of an ill cow (€) due to a de-
crease in reproductive performance of detrimen-
tal blood plasma NEFA cows. Costs were esti-
mated at €25 per case (Geishauser et al., 2001). 
For the current simulation, costs of €15, 25, and 
35 were considered.
 b  = Financial cost of pre-emptive treatment (€) 
based on the use of propylene glycol (PEG), which 
Journal of Dairy Science Vol. 97 No. 11, 2014
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is reported to allow effective treatment or preven-
tion of elevated blood plasma NEFA development 
with application rates varying between 200 and 
500 g/d during 3 wk (Johnson, 1954; Grummer 
et al., 1994; Formigoni et al., 1996; Miyoshi et al., 
2001) and costs for PEG of €1.1 /kg. 
Labor costs (e.g., for pre-emptive PEG treatment or 
for cow separation for veterinary inspection) were not 
included in the current cost estimations.
 I  = The event a cow suffers from elevated blood 
plasma NEFA.
 R = Milk fat C18:1 cis-9 concentration for that 
cow.
A threshold (θ) was selected and it was assumed to pre-
emptively treat a cow when R > θ. Hence, the prob-
ability P(I) for a cow to be ill is then given by
P(I) = P(I/R ≤ θ) × P(R ≤ θ)  
+ P(I|R > θ) × P(R > θ).
If the treatment is fully effective to treat detrimental 
blood plasma NEFA, then P(I|R > θ) = 0 and P(I) 
reduces to
P(I) = P(I|R ≤ θ) × P(R ≤ θ).
In those equations, the probability for a random cow 
to have milk fat C18:1 cis-9 less than θ, P(R ≤ θ) was 
assessed as the concentration of the number of observa-
tions with R ≤ θ to the total number of observations 
in the study. Similarly, P(R > θ) was assessed as the 
concentration of the number of cows that have R > θ 
to the total number of cows.
Under this scenario, a cost function C(θ) is built, in-
cluding 1/(financial loss of a detrimental blood plasma 
cow when not treated), that is, all detrimental blood 
plasma cows with R ≤ θ; and 2/(financial cost of the 
pre-emptive treatment), that is, all cows with R > θ. 
Hence, the expected economic cost (C) of a cow is
C(θ) = P(I) × a + P(R > θ) × b = P(I|R ≤ θ)  
× P(R ≤ θ) × a + P(R > θ) × b.
RESULTS
Classification Based on Blood Plasma NEFA 
Thresholds and Influence of Experimental  
Factors (Dietary and Dry Period Management)
Of all 368 observations in wk 2, 3, 4, and 8 after 
parturition, 8% of the cases blood plasma NEFA were 
greater than 0.6 mmol/L. However, in the case of early 
warning (n = 92), 24% of the animals were classified at 
risk to develop detrimental blood plasma NEFA con-
centration during the first 8 wk in lactation.
Blood plasma NEFA concentrations were greater in 
early lactation (P < 0.001), and blood plasma NEFA 
was affected by dry period management (P < 0.001), 
but differences became smaller when lactation pro-
gressed (dry period management by week interaction; 
P = 0.0056; Figure 1a). Particularly, omission of the 
dry period resulted in a lower blood plasma NEFA con-
centration (P < 0.001; Figure 1a). Blood plasma NEFA 
was also affected by diet, with the glucogenic diet sup-
pressing its concentration (0.20 vs. 0.25 mmol/L for the 
glucogenic and lipogenic diet, respectively; P = 0.0219).
Identification of Milk FA Predominantly Linked  
with Blood NEFA Concentrations:  
Discriminant Analysis and Correlations
Of the 45 milk FA and C18:1 cis-9-to-C15:0 ratio 
used to perform the discriminant analysis, milk fat 
C18:1 cis-9 revealed the most discriminating variable 
for the classification of detrimental blood plasma NEFA 
cases. Identification of the most discriminating variable 
was based on the standardized canonical discriminant 
function coefficients. The second retained variable was 
C16:0. Cross-validation results for grouping based on 
all variables resulted in an overall classification accu-
racy of 79.9%. More specifically, 80.3 and 75.0% of the 
cases of the blood plasma NEFA groups 0 (specificity) 
and 1 (sensitivity) were classified correctly, respectively. 
Cross-validation based on the most discriminating milk 
FA only (i.e., C18:1 cis-9) showed overall classification 
accuracy of 78.8%, specificity of 79.1%, and sensitivity 
of 75.0%. Hence, classification based on C18:1 cis-9 was 
only slightly less specific as compared with classifica-
tion based on the full parameter set, whereas sensitivity 
was maintained. Accordingly, the potential of this single 
milk FA was further emphasized in the current paper.
In accordance with blood NEFA concentrations, milk 
fat C18:1 cis-9 concentration decreased with week in 
lactation (P < 0.001) and was lower for cows without 
or with a short dry period (P < 0.001), with differ-
ences becoming smaller and disappearing when the 
lactation progressed (dry period management by week 
interaction; P < 0.001; Figure 1b). Milk fat C18:1 cis-9 
concentration was not affected by diet (P = 0.635). 
Further detailed information on the milk FA composi-
tion, in relation to the dry period length and gluco-
genic versus lipogenic ration has been reported by van 
Knegsel et al. (2014). The relation between milk fat 
C18:1 cis-9 concentration and blood NEFA is further 
confirmed through the positive relation between both 
7060 JORJONG ET AL.
Journal of Dairy Science Vol. 97 No. 11, 2014
metabolites (Figure 2), despite a relatively modest R2 
value, indicating limited potential for direct prediction 
of the blood NEFA concentration from the milk fat 
C18:1 cis-9 concentration.
Empirical Cumulative Probability Distributions  
for Diagnosis of Detrimental Blood NEFA
Logistic curves were fitted presenting both the pro-
portion of animals at risk and not at risk of detrimental 
blood plasma NEFA in relation to the milk fat C18:1 
cis-9 concentration (ranging from 12.5 to 30.6 g/100 
g of milk FA). The β1 value for the logistic curve of 
animals with detrimental blood plasma NEFA equaled 
23.6, which indicates that 50% of all observations hav-
ing a blood plasma NEFA concentration of 0.6 mmol/L 
or more were associated with a milk fat C18:1 cis-9 
concentration equal to or greater than β1 (Figure 3a). 
This situation was associated with only 6.5% false posi-
tives (i.e., animals showing milk fat C18:1 cis-9 values 
of at least 24 g/100 g of milk FA, but with blood plasma 
NEFA <0.6 mmol/L).
Empirical Cumulative Probability Distributions  
for Early Warning of Detrimental Blood Plasma NEFA
About half of the cows (45%, n = 10) showing det-
rimental blood plasma NEFA during the first 8 wk in 
lactation showed a milk fat C18:1 cis-9 concentration 
of 24 g/100 g of milk FA or more in wk 2, with a false 
positive rate of 11.4%. When the milk fat C18:1 cis-9 
concentration was below 20 g/100 g of milk FA, the risk 
of encountering detrimental blood plasma NEFA was 
less than 15% (Figure 3b).
Economic Cost Function
Figures 4a and 4b present the costs associated with 
selective PEG treatment based on the milk fat C18:1 
cis-9 concentration. Simulations were performed assum-
ing costs associated with elevated blood plasma NEFA 
could vary between €15 and 35 per case, and costs for 
3 wk of daily PEG supplementation varying from 200 
to 500 g/d equaled €4.6 to 11.6 per case. The x-axis 
represents increasing thresholds (θ) and simulations 
were based on selective treatment of animals when R 
> θ. Thresholds varied from 1 unit below the minimum 
(S1) to 1 unit above the maximum (S2) observation in 
the current study. Accordingly, S2 (extreme right on 
the x-axis) represents a situation where none of the 
animals are treated, whereas S1 (extreme left on the 
x-axis) represents a situation where all of the animals 
are treated. When costs reach a local minimum, it is of 
economic interest to selectively treat animals. Figure 
4a represents costs associated with selective treatment 
when diagnosing elevated blood plasma NEFA. Based 
on the current data set, weekly monitoring of milk fat 
C18:1 cis-9 to selectively treat animals is of no eco-
nomic interest in general (maximum benefit of less than 
€0.5/case for the situation with the combination of the 
lowest amount of PEG and the highest cost of €35; 
Figure 4a). No treatment is most often associated with 
the greatest economic return.
Finally, Figure 4b represents costs associated with 
selective treatment of animals based on monitoring of 
milk fat C18:1 cis-9 in wk 2 after parturition (early 
warning). In this case, PEG treatment is assumed to 
prevent blood NEFA concentration to rise to detrimen-
tal levels afterward. The maximum economic benefit is 
associated with a selective treatment of animals show-
Figure 1. Blood plasma NEFA concentration (a) and milk fat 
C18:1 cis-9 concentration (b) of dairy cows fed a glucogenic or lipo-
genic diet (diet) with dry period (DP) length of 0 (black bar), 30 
(white bar), or 60 d (gray bar) during wk 2, 3, 4, and 8 of lactation 
(Wk). Values represent means per week, error bars present standard 
deviations. P-values show main effects and interaction effects.
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ing milk fat C18:1 cis-9 concentration of 23 g/100 g of 
milk FA or more. In this case, economic benefits are 
limited to €2 per cow.
DISCUSSION
Blood Plasma NEFA Threshold Value
Serum NEFA concentrations typically increase 
around parturition (0.4 to 1.2 mmol/L; Leroy et al., 
2005) and are a major characteristic of the NEB early 
postpartum. Moreover, elevated blood serum NEFA 
particularly tend to negatively affect reproductive 
performance and oocyte development (Leroy et al., 
2005). Elevated blood serum NEFA concentrations 
were further linked to increased incidence of displaced 
abomasum (Cameron et al., 1998), clinical ketosis, 
metritis, or retained placenta, with critical postpartum 
blood serum NEFA concentrations varying from 0.57 
(Ospina et al., 2010a) to 0.72 (Ospina et al., 2010b) 
and 0.8 mmol/L (Roberts et al., 2012). A threshold of 
0.6 mmol/L for blood plasma NEFA concentration was 
used in the current study.
Milk FA as an Indicator of Elevated  
Blood Plasma NEFA
During a period of NEB, NEFA in plasma are in-
creased. The major NEFA released are C16:0, C18:0, 
and C18:1 cis-9 (Hostens et al., 2012), with a further 
possible conversion of C18:0 to C18:1 cis-9 in the 
mammary gland through the action of Δ9-desaturase 
(Leroy et al., 2005). This explains the positive relation 
in the current study between milk fat C18:1 cis-9 con-
centrations and blood plasma NEFA concentrations. 
Accordingly, milk fat C18:1 cis-9 was identified to be 
useful for diagnosis and early warning of cows suffering 
from a severe NEB. However, the positive correlation 
between blood NEFA concentrations and milk C18:1 
cis-9 is only modest (R2 = 0.383), indicating that a 
direct prediction of blood NEFA concentrations from 
milk C18:1 cis-9 concentrations is not accurate (Figure 
2). Moreover, the thresholds, established here, have 
only been validated for the current diets and manage-
ment and further validation under different conditions 
is required.
Potential of Milk Fat Characteristics  
as Biomarkers for Elevated Blood Plasma  
NEFA as Compared with Other Cow-Side Tests
Currently, on-farm NEFA tests in blood are readily 
available (i.e., NEFA-C kit, Wako Chemicals USA Inc., 
Richmond, VA). However, blood tests are laborious and 
invasive. Moreover, the available cow-side blood NEFA 
test shows additional drawbacks (e.g., requirement of 
a large number of samples to justify the equipment 
costs and expert training). Hence, this kit is not well 
adaptable for on farm use. This usually impedes test-
ing capabilities to very large farms or veterinary clinics 
(Townsend, 2011). In our study, logistic curves indi-
cated that 64.3% of the animals at risk of detrimental 
blood NEFA showed milk fat C18:1 cis-9 concentrations 
of 24 g/100 g of milk FA or higher, with a specificity 
of 84.4%. Interestingly, the cross-validated discriminant 
analysis showed a specificity value of 79.1% and sensi-
tivity of 75%, with an overall correct classification rate 
of 78.8%.
Figure 2. Correlation between blood plasma NEFA and milk fat C18:1 cis-9 concentrations of wk 2, 3, 4, and 8 in lactation (n = 368; R2 
= 0.38).
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Cost Effectiveness of Selective Treatment  
Based on Biomarker Monitoring
Cow-side tests will only be used routinely to allow 
selective treatment of cows at risk when the price of 
such tests does not exceed potential gain. Hence, cost 
functions were constructed based on economic losses 
for detrimental blood NEFA, between €15 and 35/cow 
(Geishauser et al., 2001). In the current study it was 
assumed that elevated blood plasma NEFA could be 
pre-emptively treated with PEG (200 to 500 g/d during 
3 wk) of which costs were assumed to be €1.1/kg. Pro-
pylene glycol is a glucogenic precursor that has been 
used since the 1950s and is still used today for both 
treatment and prevention of ketosis before and after 
parturition. It effectively seems to increase milk pro-
duction, prevent ketosis, improve reproduction, increase 
blood glucose, and decrease blood NEFA (Nielsen and 
Ingvartsen, 2004; Lomander et al., 2012). The economic 
benefit strongly depends on the incidence rate. When 
a large proportion of animals encounter the metabolic 
problem, the most cost effective solution might be to 
treat all animals, whereas the opposite is true when the 
incidence rate is low. This is illustrated when consider-
ing all NEFA observations (diagnosis; n = 368; Figure 
4a): only 8% of the observations in wk 2, 3, 4, and 8, 
blood plasma NEFA were greater than 0.6 mmol/L. 
Hence, in this case, monitoring milk FA to diagnose and 
selectively treat animals with elevated blood plasma 
NEFA did not return any economic benefit (Figure 4a). 
However, in the case of early warning (n = 92), 24% 
of the animals were classified as at risk to develop a 
detrimental blood plasma NEFA during the first 8 wk 
in lactation (Figure 4b).
Based on the current cost effectiveness simulation, 
a maximum gain of about €2 per case was calculated 
for early warning of detrimental blood plasma NEFA. 
Obviously, costs for milk FA analysis have to be put 
in this perspective. Hence, milk fat C18:1 cis-9 seems 
promising as an early indicator of detrimental blood 
plasma NEFA, as it might be routinely analyzed 
through Fourier transform infrared spectrometry (Soy-
eurt et al., 2006; Rutten et al., 2009). A single analysis 
at a specific moment early after parturition (in the 
current case, 2 wk after calving) seems of interest in 
this respect as selective treatment of animals showing a 
milk fat C18:1 cis-9 concentration of 23 g/100 g of milk 
FA or more might suffice (Figure 4b).
CONCLUSIONS
Milk fat C18:1 cis-9 shows potential as an early 
warning biomarker for compromised metabolic status 
in dairy cows during the first 2 mo of lactation. Under 
the current feeding and management conditions, a milk 
fat C18:1 cis-9 concentration of 24 g/100 g of milk FA 
or more, measured in the second week of lactation, 
could be used as an early warning for elevated blood 
plasma NEFA (≥0.6 mmol/L).
Figure 3. (a) A logistic curve, g1, representing the cumulative 
probability distribution of milk fat C18:1 cis-9 concentration, (O) ≤ o, 
in case of elevated blood plasma NEFA (NEFA ≥0.6 mmol/L; black 
diamonds) to the total number of cases showing detrimental blood 
plasma NEFA. The logistic curve is characterized by its slope (β0 = 
0.54) and inflection point (β1 = 23.6). Similarly, cases having nondet-
rimental blood plasma NEFA proportionally to the total number of 
cases with nondetrimental blood plasma NEFA (g2) in relation to O 
≤ o (gray triangles) were presented, with β0 and β1 of 0.57 and 18.7, 
respectively. (b) A logistic curve, e1, representing the cumulative prob-
ability distribution of milk fat C18:1 cis-9 concentration of wk 2 in lac-
tation (O2) ≤ o with detrimental blood plasma NEFA (≥0.6 mmol/L; 
black diamonds) at any time between wk 2 and 8 in lactation relative 
to the total number of observations with detrimental blood plasma 
NEFA. The logistic curve is characterized by its slope (β0 = 0.56) and 
inflection point (β1 = 23.9). Similarly, cows having nondetrimental 
blood plasma NEFA (gray triangles) during the first 8 wk in lactation 
proportionally to the total number of cows with nondetrimental blood 
plasma NEFA in relation to O2 ≤ o were presented (e2), with β0 and 
β1 of 0.54 and 20.2, respectively.
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